Vimarsana
Biggest News Aggregation in the World

Launch Planned News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Launch Planned. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Launch Planned Today - Breaking & Trending Today

Alkermes Announces FDA Approval of LYBALVI for the Treatment of Schizophrenia and Bipolar I Disorder - Vimarsana News

Alkermes Announces FDA Approval of LYBALVI for the Treatment of Schizophrenia and Bipolar I Disorder

Published: June 1, 2021

-- New Oral Medication Offers Established Antipsychotic Efficacy of Olanzapine With Less Weight Gain -- -- Commercial Launch Planned for Fourth Quarter 2021 -- -- Company to Host Investor

Source: finanznachrichten.de
Related Topics:
United StatesPaul GionfriddoMarisa BorgasanoSandy CoombsEli LillyAmerican Psychiatric AssociationMental Health AmericaCompany To Host Investor Conference CallBehavioral Health SystemEli Lilly CompanyDrug AdministrationClinical Development ProgramDepartment Of PsychiatryNational Comorbidity Survey ReplicationExchange CommissionIcahn School Of Medicine At Mount SinaiAlkermes Pharma IrelandOlanzapine With Less WeightLaunch PlannedFourth QuarterHost Investor Conference Call TodayJoseph Klingenstein ProfessorIcahn SchoolRichard PopsChief Executive Officer
Alkermes Announces FDA Approval of LYBALVI™ for the Treatment of Schizophrenia and Bipolar I Disorder - Vimarsana News

Alkermes Announces FDA Approval of LYBALVI™ for the Treatment of Schizophrenia and Bipolar I Disorder

Published: June 1, 2021

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has approved LYBALVI™ (olanzapine and samidorphan)...

Source: prnewswire.co.uk
Related Topics:
United StatesPaul GionfriddoMarisa BorgasanoJoseph KlingensteinSandy CoombsEli LillyAmerican Psychiatric AssociationMental Health AmericaCompany To Host Investor Conference CallBehavioral Health SystemEli Lilly CompanyDrug AdministrationClinical Development ProgramDepartment Of PsychiatryNational Comorbidity Survey ReplicationExchange CommissionAlkermes Pharma IrelandIcahn School Of Medicine At MountOlanzapine With Less WeightLaunch PlannedFourth QuarterHost Investor Conference Call TodayIcahn SchoolRichard PopsChief Executive Officer